Important Alert for SelectQuote Investors
Bragar Eagel & Squire, P.C. is reaching out to those who have invested in SelectQuote, Inc. (NYSE: SLQT) during what is known as the class period, specifically from September 9, 2020, to May 1, 2025. This is a critical time for shareholders who may have suffered financial losses and are now faced with important legal decisions.
Details About the Class Action Lawsuit
A significant class action lawsuit has been initiated against SelectQuote. This lawsuit is an important measure taken in response to recent allegations impacting the company's credibility and trustworthiness within the investor community. The lawsuit has been filed in the United States District Court for the Southern District of New York and affects all individuals who purchased SelectQuote securities during the designated time frame.
What Investors Need to Know
The deadline for investors to apply for lead plaintiff status in this class action is approaching rapidly, with a cutoff on October 10, 2025. This presents a unique opportunity for affected individuals to take action, ensuring their rights are represented in court. It’s crucial for anyone who meets the class period criteria to consider their legal options and get involved.
Understanding the Allegations Against SelectQuote
The allegations outlined in the lawsuit reveal troubling practices by SelectQuote. According to the U.S. Department of Justice, SelectQuote is accused of receiving illegal kickbacks from health insurance companies. This misconduct allegedly involved steering Medicare beneficiaries towards enrolling in unfavorable insurance plans, compromising their healthcare needs for profit. Such actions raise significant ethical concerns and impact the company’s standing in the market.
As these serious accusations came to light on May 1, 2025, SelectQuote's share value plummeted approximately 19.2%, underscoring the gravity of the situation for investors who trusted the company. The DOJ's findings indicate that SelectQuote misled consumers about the unbiased nature of their coverage comparisons, ultimately prioritizing their own financial gain over consumer welfare.
Next Steps for Affected Investors
If you've purchased or acquired shares in SelectQuote and believe you may have incurred losses, you are encouraged to reach out to the team at Bragar Eagel & Squire. They are prepared to discuss your potential eligibility for involvement in the class action and will provide the necessary guidance to navigate this complex process.
Why It Matters
Understanding your rights as a shareholder is vital, especially in light of the allegations against SelectQuote. The outcomes of this lawsuit could set important precedents for corporate governance and shareholder protections. Engaging with a knowledgeable legal partner can enhance your ability to influence the outcome of this case.
About Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. is a law firm renowned for its specialization in representing investors in securities-related litigations. With offices in multiple states, they have a strong track record of advocating for fairness and accountability in the corporate sector. Their expertise is primarily in commercial, derivative, and complex litigation matters, making them well-equipped to assist affected investors.
Contact Information
For inquiries or to discuss your situation further, please reach out to:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
Email: investigations@bespc.com
Frequently Asked Questions
What is the deadline for investors to apply as a lead plaintiff?
The deadline is October 10, 2025.
What is the main allegation against SelectQuote?
SelectQuote is accused of receiving illegal kickbacks from health insurance companies while misleading consumers.
Who can participate in the class action lawsuit?
Anyone who purchased SelectQuote securities during the specified class period is eligible.
Why should investors pay attention to this lawsuit?
This case could influence the accountability of corporations regarding their dealings with shareholders.
How can affected investors learn more about their rights?
Affected investors can contact Bragar Eagel & Squire for detailed guidance and support.
